Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

被引:796
作者
Chan, Raymond H. [1 ,2 ]
Maron, Barry J. [3 ]
Olivotto, Iacopo [4 ]
Pencina, Michael J. [5 ,6 ]
Assenza, Gabriele Egidy [7 ]
Haas, Tammy [3 ]
Lesser, John R. [3 ]
Gruner, Christiane [8 ]
Crean, Andrew M. [8 ]
Rakowski, Harry [8 ]
Udelson, James E. [9 ]
Rowin, Ethan [9 ]
Lombardi, Massimo [10 ]
Cecchi, Franco [4 ]
Tomberli, Benedetta [4 ]
Spirito, Paolo [11 ]
Formisano, Francesco [11 ]
Biagini, Elena [12 ]
Rapezzi, Claudio [12 ]
De Cecco, Carlo Nicola [7 ]
Autore, Camillo [7 ]
Cook, E. Francis [13 ]
Hong, Susie N. [1 ,2 ]
Gibson, C. Michael [1 ,2 ]
Manning, Warren J. [1 ,2 ]
Appelbaum, Evan [1 ,2 ]
Maron, Martin S. [9 ]
机构
[1] Harvard Univ, Sch Med, PERFUSE Study Grp, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Med, Cardiovascular Div,Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA
[4] Azienda Osped Univ Careggi, Referral Ctr Myocardial Dis, Florence, Italy
[5] Harvard Clin Res Inst, Boston, MA USA
[6] Boston Univ Biostat, Boston, MA USA
[7] Univ Roma La Sapienza, Osped St Andrea, I-00185 Rome, Italy
[8] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Div Cardiol, Toronto, ON M5G 1L7, Canada
[9] Tufts Med Ctr, Hypertroph Cardiomyopathy Ctr, Div Cardiol, Boston, MA USA
[10] Fdn CNR Reg Toscana G Monasterio, Pisa, Italy
[11] Osped Galliera, Ente Osped, Genoa, Italy
[12] St Orsola Marcello Malpighi Hosp, Bologna, Italy
[13] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
cardiomyopathies; heart arrest; magnetic resonance imaging; LATE GADOLINIUM ENHANCEMENT; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; MYOCARDIAL FIBROSIS; VENTRICULAR TACHYARRHYTHMIA; CLINICAL-SIGNIFICANCE; CARDIAC DEATH; PREVENTION; YOUNG; TACHYCARDIA; PREVALENCE;
D O I
10.1161/CIRCULATIONAHA.113.007094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden death in the young, although not all patients eligible for sudden death prevention with an implantable cardioverter-defibrillator are identified. Contrast-enhanced cardiovascular magnetic resonance with late gadolinium enhancement (LGE) has emerged as an in vivo marker of myocardial fibrosis, although its role in stratifying sudden death risk in subgroups of HCM patients remains incompletely understood. Methods and Results-We assessed the relation between LGE and cardiovascular outcomes in 1293 HCM patients referred for cardiovascular magnetic resonance and followed up for a median of 3.3 years. Sudden cardiac death (SCD) events (including appropriate defibrillator interventions) occurred in 37 patients (3%). A continuous relationship was evident between LGE by percent left ventricular mass and SCD event risk in HCM patients (P=0.001). Extent of LGE was associated with an increased risk of SCD events (adjusted hazard ratio, 1.46/10% increase in LGE; P=0.002), even after adjustment for other relevant disease variables. LGE of >= 15% of LV mass demonstrated a 2-fold increase in SCD event risk in those patients otherwise considered to be at lower risk, with an estimated likelihood for SCD events of 6% at 5 years. Performance of the SCD event risk model was enhanced by LGE (net reclassification index, 12.9%; 95% confidence interval, 0.3-38.3). Absence of LGE was associated with lower risk for SCD events (adjusted hazard ratio, 0.39; P=0.02). Extent of LGE also predicted the development of end-stage HCM with systolic dysfunction (adjusted hazard ratio, 1.80/10% increase in LGE; P<0.03). Conclusions-Extensive LGE measured by quantitative contrast enhanced CMR provides additional information for assessing SCD event risk among HCM patients, particularly patients otherwise judged to be at low risk.
引用
收藏
页码:484 / 495
页数:12
相关论文
共 54 条
[1]   Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy [J].
Adabag, AS ;
Casey, SA ;
Kuskowski, MA ;
Zenovich, AG ;
Maron, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (05) :697-704
[2]  
Alpendurada Francisco, 2009, Curr Cardiol Rep, V11, P61
[3]   Usefulness of Delayed Enhancement by Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy as a Marker of Disease and Its Severity [J].
Aquaro, Giovanni Donato ;
Masci, Piergiorgio ;
Formisano, Francesco ;
Barison, Andrea ;
Strata, Elisabetta ;
Pingitore, Alessandro ;
Positano, Vincenzo ;
Spirito, Paolo ;
Lombardi, Massimo .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (03) :392-397
[4]   Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia [J].
Basso, C ;
Thiene, G ;
Corrado, D ;
Buja, G ;
Melacini, P ;
Nava, A .
HUMAN PATHOLOGY, 2000, 31 (08) :988-998
[5]   Effects of myocardial fibrosis assessed by MRI on dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a retrospective database analysis [J].
Biagini, Elena ;
Lorenzini, Massimiliano ;
Olivotto, Iacopo ;
Rocchi, Guido ;
Lovato, Luigi ;
Lai, Francesco ;
Rosmini, Stefania ;
Pazzi, Chiara ;
Pasquale, Ferdinando ;
Reggiani, Maria Letizia Bacchi ;
Fattori, Rossella ;
Rapezzi, Claudio .
BMJ OPEN, 2012, 2 (05)
[6]   Extensive Myocardial Fibrosis in a Patient With Hypertrophic Cardiomyopathy and Ventricular Tachycardia Without Traditional High-Risk Features [J].
Bongioanni, Sergio ;
Spirito, Paolo ;
Masi, Andrea Sibona ;
Chiribiri, Amedeo ;
Bonamini, Rodolfo ;
Conte, Maria Rosa .
CIRCULATION-CARDIOVASCULAR IMAGING, 2009, 2 (04) :349-350
[7]   Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy [J].
Bruder, Oliver ;
Wagner, Anja ;
Jensen, Christoph J. ;
Schneider, Steffen ;
Ong, Peter ;
Kispert, Eva-Maria ;
Nassenstein, Kai ;
Schlosser, Thomas ;
Sabin, Georg V. ;
Sechtem, Udo ;
Mahrholdt, Heiko .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (11) :875-887
[8]   Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart - A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association [J].
Cerqueira, MD ;
Weissman, NJ ;
Dilsizian, V ;
Jacobs, AK ;
Kaul, S ;
Laskey, WK ;
Pennell, DJ ;
Rumberger, JA ;
Ryan, T ;
Verani, MS .
CIRCULATION, 2002, 105 (04) :539-542
[9]   Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy [J].
Choudhury, L ;
Mahrholdt, H ;
Wagner, A ;
Choi, KM ;
Elliott, MD ;
Klocke, FJ ;
Bonow, RO ;
Judd, RM ;
Kim, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (12) :2156-2164
[10]   Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients [J].
Elliott, PM ;
Poloniecki, J ;
Dickie, S ;
Sharma, S ;
Monserrat, L ;
Varnava, A ;
Mahon, NG ;
McKenna, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2212-2218